-John C Wain Researcher Activity Profile

Research Author Detailed Information 

John C Wain Publication Rate By Year

John C Wain has published 1 paper(s) in 2004, 7 paper(s) in 2006, 8 paper(s) in 2007, 9 paper(s) in 2008, for a total of 25 research publications in total.

John C Jc Wain Author Information

LAST NAME: wain

FIRST NAME: John C

INITIALS: jc

AFFILIATION:

Papers

John C Wain's Publication Record

1. Smoking cessation before diagnosis and survival in early stage non-small cell lung cancer patients. Year Published: 2006
Department of Environmental Health, Harvard School of Public Health, Boston, MA, USA. wzhou@hohp.harvard.edu
2. Polymorphisms of vitamin D receptor and survival in early-stage non-small cell lung cancer patients. Year Published: 2006
Departments of Environmental Health, Occupational Health Program, Harvard School of Public Health, 665 Huntington Avenue, Boston, MA 02115, USA. wzhou@hsph.harvard.edu
3. Second hand smoke exposure and survival in early-stage non-small-cell lung cancer patients. Year Published: 2006
Department of Environmental Health, Harvard School of Public Health, Boston, MA 02115, USA. wzhou@hsph.harvard.edu
4. Thymectomy does not abrogate long-term acceptance of MHC class I-disparate lung allografts in miniature Swine. Year Published: 2006
Transplantation Biology Research Center, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
5. The role of indirect recognition of MHC class I and II allopeptides in a fully mismatched miniature swine model of lung transplantation. Year Published: 2006
Transplantation Biology Research Center, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
6. An MHC class II disparity raises the threshold for tolerance induction in pulmonary allografts in miniature swine. Year Published: 2006
Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
7. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. Year Published: 2007
Departments of Environmental Health, Harvard School of Public Health, Boston, MA 02115, USA. wzhou@hsph.harvard.edu
8. XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk. Year Published: 2007
Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA. geoffrey.liu@uhn.on.ca
9. Genetic polymorphisms of MDM2, cumulative cigarette smoking and nonsmall cell lung cancer risk. Year Published: 2007
Applied Molecular Oncology/Department of Medicine, Ontario Cancer Institute/Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada. geoffrey.liu@uhn.on.ca
10. Operational tolerance to class I disparate lungs can be induced despite pretransplant immunization with class I allopeptides. Year Published: 2007
Transplantation Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
11. Genetic polymorphisms of MDM2, cumulative cigarette smoking and nonsmall cell lung cancer risk. Year Published: 2007
Applied Molecular Oncology/Department of Medicine, Ontario Cancer Institute/Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada. geoffrey.liu@uhn.on.ca
12. A rapid outcomes ascertainment system improves the quality of prognostic and pharmacogenetic outcomes from observational studies. Year Published: 2008
Princess Margaret Hospital/Ontario Cancer Institute, Suite 7-124, 610 University Avenue, Toronto, Ontario, Canada M5G 2M9. Geoffrey.Liu@uhn.on.ca.
13. Induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVA thymic tumors. Year Published: 2008
Division of Thoracic Surgery, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. wright.cameron@mgh.harvard.edu
14. Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer. Year Published: 2008
Authors' Affiliations: Departments of Environmental Health, Hematology-Oncology, and Medicine and Medical Biophysics, Princess Margaret Hospital/Ontario Cancer Institute, University of Toronto, Toronto, Ontario, Canada.
15. Operational tolerance to class I disparate lungs can be induced despite pretransplant immunization with class I allopeptides. Year Published: 2007
Transplantation Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
16. Post-esophagectomy gastric outlet obstruction: role of pyloromyotomy and management with endoscopic pyloric dilatation. Year Published: 2007
Massachusetts General Hospital, 55 Fruit Street, Blake 1570, Boston, MA 02114, United States. Mlanuti@partners.org
17. Mucinous cystadenoma of the lung. Year Published: 2004
Department of Radiology, Division of Thoracic Radiology, Massachusetts General Hospital and Harvard University, 55 Fruit St., Boston, MA 02114, USA.
18. Genetic polymorphisms of MDM2, cumulative cigarette smoking and nonsmall cell lung cancer risk. Year Published: 2007
Applied Molecular Oncology/Department of Medicine, Ontario Cancer Institute/Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada. geoffrey.liu@uhn.on.ca
19. A rapid outcomes ascertainment system improves the quality of prognostic and pharmacogenetic outcomes from observational studies. Year Published: 2008
Princess Margaret Hospital/Ontario Cancer Institute, 610 University Avenue, Toronto, Ontario, Canada.
20. VEGF polymorphisms and survival in early-stage non-small-cell lung cancer. Year Published: 2008
Massachusetts General Hospital, Harvard School of Public Health, 665 Huntington Ave, Boston, MA 02115, USA.
21. Polymorphisms of inflammatory and metalloproteinase genes, Helicobacter pylori infection and the risk of oesophageal adenocarcinoma. Year Published: 2008
1Medical Oncology, Department of Medicine, Princess Margaret Hospital, University of Toronto, 610 University Avenue, Toronto, Ontario, Canada M5G 2M9.
22. Mechanical ventilation and air leaks after lung biopsy for acute respiratory distress syndrome. Year Published: 2006
Division of Pulmonary , Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. mcho@bidmc.harvard.edu
23. Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer. Year Published: 2008
Department of Environmental Health, Princess Margaret Hospital/Ontario Cancer Institute, University of Toronto, Toronto, Ontario, Canada.
24. A rapid outcomes ascertainment system improves the quality of prognostic and pharmacogenetic outcomes from observational studies. Year Published: 2008
Princess Margaret Hospital/Ontario Cancer Institute, 610 University Avenue, Toronto, Ontario, Canada.
25. Polymorphisms of inflammatory and metalloproteinase genes, Helicobacter pylori infection and the risk of oesophageal adenocarcinoma. Year Published: 2008
Medical Oncology, Department of Medicine, Princess Margaret Hospital, University of Toronto, 610 University Avenue, Toronto, Ontario, Canada M5G 2M9.